Rhino 50K Supplement Recall [US]

US/Silver Spring: AMA Wholesale Inc., a Woodland Hills, California establishment, recalls certain batch/lots of Rhino 69 Extreme 50000 Dietary Supplement Capsules due to suspected presence of Tadalafil, a controlled substance available only under prescription, rendering this Supplement an unapproved drug due to the possibility of fatal cardiovascular events, all serious health hazards. FDA: http://ht.ly/gfKG30jyV2G

Direct link: https://www.fda.gov/Safety/Recalls/ucm604633.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Supplements are subject to this recall:

Advertisements

NOW Foods branded Vitamin A Recall [UK]

UK/London: Power Body Nutrition Ltd., a United Kingdom establishment, recalls all current batch/lots of NOW Foods branded Vitamin A 25,000 IU from Fish Liver Oil Capsules because this medication may exceed the maximum recommended intake of Vitamin A allowed under UK health regulations, a serious health hazard. FSA: http://ht.ly/e8Hq30jnZmt

Direct link: https://www.food.gov.uk/news-updates/news/2018/17030/power-body-nutrition-ltd-recalls-fish-liver-oil

Additional information:
The UK Food Standards Agency (“FSA”) reports the following Vitamin pills are subject to recall:

First Aid Research Bacitraycin Plus Ointment Recall [US]

US/Washington: First Aid Research recalls an estimated 500,000 tubes of Maximum Strength Bacitraycin Plus Ointment with Lidocaine due to suspected failure to meet the child resistant packaging requirements of the Poison Prevention Packaging Act and consequential risk of child injury and/or poisoning, all serious health hazards. CPSC: http://ht.ly/DKl530jmP2a

Direct link: https://www.cpsc.gov/Recalls/2018/First-Aid-Research-Recalls-Maximum-Strength-Bacitraycin-Plus-Ointment-With-Lidocaine-Due-to-Failure-to-Meet-Child-Resistant-Closure-Requirement

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves Maximum Strength Bacitraycin Plus Ointment with Lidocaine.

Rite Aid branded Digital Thermometer Recall [Australia]

Australia/Canberra: ToLife Technologies Pty Ltd, a Welshpool, Western Australia establishment, recalls certain batch/lots of Rite Aid branded Mini Digital Temple Touch Thermometers due to suspected failure to secure the battery compartment, component detachment and consequential risk of choking, oral injury, internal ingestion, internal chemical burns, GI tract laceration damage and death, all serious health and safety hazards.

ACCC: http://ht.ly/4I2S30iYJTn

Direct link: https://www.productsafety.gov.au/recall/tolife-technologies-pty-ltd-rite-aid-mini-digital-temple-touch-thermometerhttp://ht.ly/4I2S30iYJTn

Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following Digital Thermometers are subject to this recall:

Tecentriq (Atezolizumab) Warning [Canada]

Canada/Ottawa: Health Canada, a Canadian health regulatory authority, warns patients, physicians and other healthcare professionals that Tecentriq (Atezolizumab) may increase the risk of Myocarditis, a serious health and safety hazards. HCSC: http://ht.ly/fJC630iwzoN

Direct link: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/65990a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following drug products are subject to this recall:

Primus Pharma Limbrel Medical Food Recall [US]

US/Silver Spring: Primus Pharmaceuticals, Inc., a Scottsdale, Arizona establishment, recalls all unexpired batch/lots of Limbrel Medical Food products due to suspected
rare but serious and side effects, all serious health hazard. FDA: http://ht.ly/zotI30i64Fy

Direct link: https://www.fda.gov/Safety/Recalls/ucm594357.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Limbrel Medical Food products are subject to this recall:

Magno-Humphries Basic Drugs Senna Laxative Recall [US]

US/Silver Spring: Magno-Humphries Laboratories, Inc. recalls certain batch/lots of Basic Drugs branded Senna Laxative due to mislabeling, suspected presence of Naproxen Sodium, a non-steroidal anti-inflammatory drug (“NSAID”) and consequential risk of fatal adverse events in patients with underlying illnesses, all serious health and safety hazards. FDA: http://ht.ly/7dqq30hW0VE

Direct link: https://www.fda.gov/Safety/Recalls/ucm593150.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Basic Drugs branded Senna Laxative products are subject to this recall: